Found 13 matching trials
Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
PHASE3This Study is A Double-blind, Randomized, Placebo-controlled, Multi-center,...
Location
Chung-ang University Hospital
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002
PHASE3The primary objective is to demonstrate the safety and efficacy of DWP-450 ...
Location
The Clinical Testing Center of Beverly Hills
Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)
PHASE3The purpose of this study is to explore the Efficacy and Safety of DWP450 f...
Location
Multiple Locations
Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines
PHASE2The purpose of this study is to demonstrate the safety of multiple doses of...
Location
ATS Clinical Research
DWP450 for Treating Moderate to Severe Glabellar Lines
PHASE3A multi-center, randomized, double-blind, positive drug-controlled clinical...
Location
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines
PHASE2The purpose of this study is to evaluate the Efficacy and Safety of DWP450 ...
Location
Konkuk University Medical Center
Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
PHASE4Study Design: Randomized Single Blind Study Objective: To determine the dos...
Location
Seoul Metropolitan Government-Seoul National University Boramae Medical Center
DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy
PHASE2This study is A Randomized, Double-blind, Placebo-controlled, Phase II Opti...
Location
Multiple Locations
Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
PHASE3The purpose of this study was to observe Efficacy and safety of DWP450 comp...
Location
Chung-Ang University Hospital
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
PHASE3The primary objective is to demonstrate the safety and efficacy of DWP-450 ...
Location
Steven Fagien, MD